I think it's possible the DMC can simply recommend 2 x 2mg/kg and for the trial to move directly to stage 2. If this is the case then the stage 1 results will be used to establish 2 x 2mg/kg as the minimum effective dose, so won't be a complete waste. There will be a slight setback since the durability study will be delayed. The second option will be for PAR to go back to the FDA and get the IND amended to include 2 x 2mg/kg and possibly start from stage 1 again. It's obviously complicated since none of the P2 trials for iPPS have been conducted in the USA, but given the presumed lack of AE's in the stage 1 trial then the DMC should be confident enough to allow the 2 x 2mg/kg dose to be used.
All IMO, dyor
- Forums
- ASX - By Stock
- PAR
- AGM 2024 - QUESTIONS
AGM 2024 - QUESTIONS, page-58
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 24.5¢ | $265.4K | 1.050M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 130186 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 11571 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 130186 | 0.245 |
8 | 120363 | 0.240 |
5 | 126753 | 0.235 |
5 | 146782 | 0.230 |
2 | 53000 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 11571 | 1 |
0.260 | 15236 | 1 |
0.265 | 59987 | 2 |
0.270 | 10000 | 1 |
0.275 | 16347 | 3 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online